{"filings":[{"id":104703,"accession_number":"0001493152-26-004370","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2026-01-30T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Hypha Labs dismisses Fruci & Associates, engages Astra Audit for FY2026","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board approved dismissal of Fruci & Associates II, PLLC and engagement of Astra Audit and Advisory, LLC for FY ending Sept 30, 2026.","Fruci's reports on FY2024 and FY2025 included explanatory paragraphs questioning going concern but no adverse opinions.","No disagreements or reportable events occurred during Fruci's engagement.","No pre-engagement consultations with Astra regarding accounting principles or audit opinions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173473,"accession_number":"0001493152-25-003647","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2025-01-24T23:59:59+00:00","items":["1.01","5.02","5.05","9.01"],"status":"ready","headline":"Hypha Labs enters amended consulting agreement with CEO's entity for $120K/year","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended and Restated Consulting Agreement with Duck's Nest Investments (wholly-owned by CEO A. Stone Douglass) effective Jan 1, 2025.","Consultant to receive $10,000/month ($120,000/year) for services including Chairman, President, CEO, CFO, Secretary roles.","Agreement has one-year term renewable annually; requires minimum 15 hours/week.","Company also adopted a new Code of Conduct and Business Ethics effective Jan 24, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173472,"accession_number":"0001493152-25-002568","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2025-01-16T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Hypha Labs increases authorized common shares to 880M and preferred to 70M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Certificate of Amendment filed with Nevada SOS, effective January 15, 2025.","Authorized common stock increased from 250M to 880M shares (3.5x increase).","Authorized preferred stock increased from 10M to 70M shares (7x increase)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190462,"accession_number":"0001493152-24-050186","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2024-12-16T23:59:59+00:00","items":["1.01","5.07","3.02","9.01"],"status":"ready","headline":"CEO acquires Series C Preferred shares with super-voting rights; approved 3.5x increase in authorized shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On Dec 10, 2024, CEO A. Stone Douglass purchased 1,000 shares of Series C Preferred at $0.10/share, each carrying 200,000 votes.","Series C shares are not convertible, pay no dividends, are non-redeemable, and have a $0.10/share liquidation preference.","Purpose: to allow CEO to vote a majority to amend Articles to increase authorized common from 250M to 880M and preferred from 10M to 70M.","Amendment approved by written consent of CEO as sole Series C holder; effective upon filing with Nevada Secretary of State.","Sale was exempt from registration under Section 4(a)(2) of the Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224253,"accession_number":"0001493152-24-014583","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2024-04-15T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Digipath renames to Hypha Labs after selling testing business; symbol change planned","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Effective March 12, 2024, name changed from Digipath, Inc. to Hypha Labs, Inc. via Article 1 amendment.","Name change follows sale of testing business (Digipath Labs) on February 20, 2024; Digipath name transfers to buyer.","Company plans to change OTC trading symbol from DIGP to a new symbol soon.","No stockholder vote required under Nevada law (N.R.S. 78.390(1)(a))."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243591,"accession_number":"0001493152-24-008427","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2024-03-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"President Todd Denkin resigns; A. Stone Douglass appointed President and CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Todd Denkin resigned as President of Digipath and Digipath Labs effective Feb 28, 2024 to pursue other opportunities.","A. Stone Douglass, current Chairman, CFO, and Secretary, appointed as President and CEO effective Feb 29, 2024.","Mr. Douglass has a consulting agreement with the Company providing a monthly fee of $5,000."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243590,"accession_number":"0001493152-24-007618","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2024-02-23T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"Digipath completes sale of Digipath Labs' assets to DPL NV LLC for $2.3M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale closed on Feb 20, 2024, after Nevada CCB approval on Jan 18, 2024.","Cash proceeds at closing of $2,240,004.50, including $72,022.67 working capital surplus and $97,981.83 available cash.","Buyer deposited $230,000 into escrow for 12 months to satisfy potential indemnification claims.","Working capital adjustment will be resolved within 65 days post-closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261007,"accession_number":"0001493152-23-035088","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2023-10-03T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Digipath dismisses M&K CPAS, engages Fruci & Associates as new auditor for FY2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved dismissal of M&K CPAS and engagement of Fruci & Associates II, PLLC as independent auditor for fiscal year ending Sep 30, 2023.","M&K's prior reports included going concern qualification but no adverse opinions or disagreements.","No reportable events or consultations with Fruci prior to engagement.","M&K letter confirming agreement with statements filed as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296388,"accession_number":"0001493152-23-015225","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2023-05-03T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Digipath agrees to sell cannabis testing lab assets for $2.3M; director resigns","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Asset purchase price $2.3M cash; adjustments based on working capital above/below $150K.","Closing subject to Nevada Cannabis Compliance Board approval by June 30, 2024; either party may terminate.","Buyer deposited $230K into escrow for 12-month indemnification post-closing.","Management Services Agreement: buyer manages lab; monthly fee $10K + 15% of cash collections to Digipath (min $15K).","Director Bruce Raben resigned effective May 2, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":352549,"accession_number":"0001493152-22-020337","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2022-07-26T23:59:59+00:00","items":["1.01","3.03","5.03","9.01"],"status":"ready","headline":"Digipath sells 1,000 Series C Preferred shares to President Todd Denkin at $0.10/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["President Todd Denkin purchased 1,000 shares of Series C Preferred Stock for $100 total ($0.10 per share).","Each Series C share grants 200,000 votes to executive officers, but no conversion, dividends, or redemption rights.","Series C has liquidation preference over common stock at stated value of $0.10 per share.","Board approved Certificate of Designation filed July 20, 2022; company cites limited financial resources as rationale.","The sale may enable future strategic transactions on an expedited basis, according to the Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":389227,"accession_number":"0001493152-22-007735","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2022-03-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Digipath terminates LOI to acquire C3 Labs, expects full recovery of $1M loan via equipment liquidation","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Terminated letter of intent with Evio, Inc. to acquire controlling interest in C3 Labs, a cannabis testing lab in Berkeley, CA.","Had advanced approximately $1,000,000 in secured loans to C3 Labs prior to termination.","Company is in possession of C3 Labs equipment and is in the process of liquidating it.","Anticipates liquidation proceeds will be sufficient to repay all amounts owed by C3 Labs in full."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":389226,"accession_number":"0001493152-22-000553","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2022-01-06T23:59:59+00:00","items":["1.01","3.02","3.03","5.03","9.01"],"status":"ready","headline":"Digipath exchanges 278K Series A for Series B preferred, raises $55.6K","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exchanged 278,000 shares of Series A Preferred for 278,000 shares of Series B Preferred with an institutional investor.","Investor purchased 55,600 additional Series B shares at $1.00 per share, gross proceeds $55,600.","Series B Preferred has a stated value of $1.00 and is convertible into common stock at $0.04 per share.","Series B Preferred ranks senior to common stock upon liquidation, entitled to $1.00 per share.","Transactions were unregistered, relying on Section 3(a)(9) for exchange and Rule 506 for cash sale."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":426140,"accession_number":"0001493152-21-020584","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2021-08-18T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Digipath appoints A. Stone Douglass as CFO effective August 16, 2021","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["A. Stone Douglass, 74, appointed CFO; had been a director since July 1, 2021.","Previously served as consultant; awarded option for 1,000,000 shares at $0.06 on June 2, 2021.","No other agreements with Digipath; holds multiple outside executive roles."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":426139,"accession_number":"0001493152-21-016285","cik":1502966,"company_name":"Hypha Labs, Inc.","ticker":"FUNI","form_type":"8-K","filed_at":"2021-07-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Digipath appoints Stone Douglass to board, Todd Denkin as President","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stone Douglass appointed to Board on July 1, 2021; received option for 1M shares at $0.06 exercise price.","Todd Denkin appointed President; previously consultant via TD Media (500K shares, $8k/month).","Denkin awarded 1.5M shares of common stock and $150k annual salary, replacing consulting arrangement.","Denkin previously served as CEO (2014-2016) and President (2014-2019); returns to management role."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2245375.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}